Rohit N. Kulkarni
NIH Rank #681
- Program Leader
- Top 5% Funded
- R01 Holder
- Multi-Institutional
- Early Career
- Diverse Portfolio
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 2237742Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Internal Medicine
NIH Funding · FY2024
Linked Award Amount
$6.8M
Full award amounts, FY2024
Award Records
9
Records listing this PI
Award-Linked Rank
#681
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Rohit N. Kulkarni as a PI. Multi-PI records show the full award amount for context.
- $2Maward amount
- 5U01DK137242-02U01Development of platforms for beta cell-specific delivery and ligand discovery$962.4Kaward amount
- 5U01DK135095-03U01Using ex vivo, in vivo models and patient mutations to interrogate pancreatic exocrine-endocrine cross talk$904.1Kaward amount
- 5R01DK133847-03R01Characterization of beta-cell-specific extracellular vesicle cargo as functional biomarkers for type I DM disease$718Kaward amount
- 5R01DK105588-10R01Role of 12-lipoxygenase and 12-HETE signaling in beta-cell dysfunction$624.9Kaward amount
- 5R01DK132900-02R01Development of platforms for sorting, production, editing of beta cells$623.5Kaward amount
- 5R01DK129464-04R01Interrogating the ubiquitin pathway to understand and treat cytokine-induced beta-cell death in type 1 diabetes$512.3Kaward amount
- $284.3Kaward amount
- 3R01DK105588-10S1R01Role of 12-lipoxygenase and 12-HETE signaling in beta-cell dysfunction$92.4Kaward amount
Award organizations
Organizations that administered FY2024 awards listing Rohit N. Kulkarni as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardJoslin Diabetes Center
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024$5M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #681
- 2024Entered Top 25% NationallyRanked #681
- 2024Entered Top 10% NationallyRanked #681
- 2024Entered Top 5% NationallyRanked #681
- 2025$10M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 4 institutions
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Rohit N. Kulkarni.
Amit Choudhary
Broad Institute, Inc.
6
shared awards
Alessandro Doria
Joslin Diabetes Center
3
shared awards
Ali Naji
Joslin Diabetes Center
3
shared awards
Amy Jo Wagers
Joslin Diabetes Center
3
shared awards
Chuan He
Joslin Diabetes Center
3
shared awards
Jean E. Schaffer
Joslin Diabetes Center
3
shared awards
Jeffrey Michael Karp
Broad Institute, Inc.
3
shared awards
Laurie J Goodyear
Joslin Diabetes Center
3
shared awards
Lori M Laffel
Joslin Diabetes Center
3
shared awards
Mengjie Chen
Joslin Diabetes Center
3
shared awards